Bavarian Nordic to invest $75M in fill/finish line in Denmark

Bavarian Nordic will invest approximately USD 75 million over the coming years in the construction of a fill/finish manufacturing line at its facility in Denmark to support the IMVAMUNE stockpile.

“Bavarian Nordic will invest approximately USD 75 million over the coming years in the construction of a fill/finish manufacturing line at its facility in Denmark.”biospace.com

• 1 source
• biospace.comBavarian Nordic Secures Contract Award For Supply Of Freeze-Dried IMVAMUNE Smallpox Vaccine To The U.S. Government - BioSpaceHeather McKenzieSep 28, 2017

Summarized from public sources; check the original articles before acting on it.